White label ELPA - ClinicalTrials.eu

Study on Fazirsiran for Patients with Alpha-1 Antitrypsin Deficiency Liver Disease and Mild Fibrosis

Recruiting

3 1 1
Investigated diseases:
- Alpha-1 antitrypsin deficiency
Investigated drugs:
- Fazirsiran
- Saline
+4
Study Comparing Givinostat and Hydroxyurea for Patients with High-Risk Polycythemia Vera

Recruiting

3 1 1 1
Investigated diseases:
- Polycythaemia vera
Investigated drugs:
+5
Study on the Long-term Safety of TAK-861 for Patients with Narcolepsy Type 1

Recruiting

4 1 1
Investigated diseases:
- Narcolepsy
Investigated drugs:
- N-{(2S,3R)-4,4-Difluoro-1-(2-Hydroxy-2-Methylpropanoyl)-2-[(2,3′,5′-Trifluoro[1,1′-Biphenyl]-3-Yl)Methyl]Pyrrolidin-3-Yl}Ethanesulfonamide
+5
Study on the Effect of Ketoprofen and Drug Combination for Managing Pain After Heart Surgery in Patients

Recruiting

3 1 1
Investigated diseases:
- Procedural pain
Investigated drugs:
Study on Gabapentin for Treating Nerve Pain in the Leg from Lower Back Pain

Recruiting

3 1 1
Investigated diseases:
- Back pain
Investigated drugs:
- Gabapentin
- Gelatin
Study on Meldonium and Physical Activity for Patients with Heart Failure with Preserved Ejection Fraction

Recruiting

3 1 1 1
Investigated diseases:
- Cardiac failure chronic
- Heart failure with preserved ejection fraction
Investigated drugs:
- Meldonium
Study on the Safety and Effects of XL092 with Nivolumab, Ipilimumab, and Relatlimab for Patients with Advanced Solid Tumors

Recruiting

1 1 1 1
Investigated drugs:
+1
Study on the Effects of Saccharomyces boulardii CNCM I-745 and Amoxicillin on Gut Health in Patients with Early Lyme Disease Undergoing Antibiotic Treatment

Recruiting

3 1 1
Investigated diseases:
- Erythema migrans
Investigated drugs:
- Saccharomyces Boulardii Cncm I-745 Lyophilized
- Amoxicillin
Study on Mesenchymal Stromal Cells (MC0518) for Treating Steroid-Resistant Acute Graft Versus Host Disease in Adults and Adolescents

Recruiting

3 1 1 1
Investigated diseases:
- Acute graft versus host disease
Investigated drugs:
Study Comparing Sacituzumab Govitecan Alone and with Pembrolizumab for Patients with Low-Risk, Triple-Negative Early Breast Cancer

Recruiting

2 1 1 1
Investigated drugs:
- Sacituzumab Govitecan
- Pembrolizumab

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies